Paid Clinical Trials in Mobile, AL
As of July 2026, 121 paid clinical trials are recruiting in Mobile, Alabama. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Mobile offers studies at sites including USA Health Strada Patient Care Center for conditions such as Heart Failure, Breast Cancer, Crohn's Disease, Malignant Solid Neoplasm. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Mobile
Trials by drug in Mobile
Filter results
Newly added in Mobile
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
116 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Study of DONQ52 in Active Celiac Disease
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Top Research Study Locations in Mobile
Researchers run research studies in Mobile, AL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| USA Health Strada Patient Care Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Mixed Phenotype Acute Leukemia | 16 |
| Mobile Infirmary Medical Center | Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Acral Lentiginous Melanoma | 11 |
| University of South Alabama | Cancer, Covid19, Depressive Symptoms | 8 |
| University of South Alabama Mitchell Cancer Institute | Malignant Female Reproductive System Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm, Recurrent Malignant Solid Neoplasm | 7 |
| Infirmary Cancer Care | Extensive-stage Small Cell Lung Cancer (ES-SCLC), Extra-pulmonary Neuroendocrine Carcinoma, Follicular Lymphoma | 6 |
| GSK Investigational Site | Asthma, Bronchiectasis, Chickenpox | 5 |
| USA Mitchell Cancer Institute | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Triple Negative Breast Neoplasms | 4 |
| AMR Clinical | Healthy Adults, Osteoarthritis, Overweight or Obesity | 3 |
| East View Medical Research | Celiac Disease, Crohn Disease, Crohn's Disease | 3 |
| AMR Mobile | Acute Migraine, Migraine | 2 |
| Cardiology Associates of Mobile | Heart Failure, Heart Failure NYHA Class II, Heart Failure NYHA Class III | 2 |
| USA Health Children's and Women's Hospital | Healthy, RSV Infection | 2 |
| Urology Associates of Mobile | Hematuria - Cause Not Known, Intermediate Risk Non-Muscle Invasive Bladder Cancer | 2 |
| USA Health Mitchell Cancer Institute | Healthy, Ovarian Cancer | 2 |
| AMR Clinical Mobile | Lipoprotein(a) | 1 |
| Alliance for Multispecialty Research - Mobile | Vulvovaginal Candidiases, Vulvovaginal Candidiasis (VVC), Vulvovaginal Candidiasis, Genital | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| CB Flock Research Corporation | Cardiovascular Disease | 1 |
| Cardiology Associates | Coronary Artery Disease Progression, Coronary Artery Disease Risk Factors Multiple, Premature Atherosclerosis | 1 |
| Children and Woman's Hospital | Postoperative Pain | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Diagnostic and Medical Clinic | Heart Failure | 1 |
| East View Medical Research | Crohn's Disease | 1 |
| Ferring Investigational Site | Bowel Preparation | 1 |
| Focus-MD | Attention Deficit Disorder (ADD), Attention Deficit Disorder With Hyperactivity (ADHD) | 1 |
Active & Upcoming Studies in Mobile (2026)
Recruiting trials in Mobile grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (49 active studies)
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy · Phase 3 · Boehringer Ingelheim
- A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · Phase 4 · Eli Lilly and Company
Cardiovascular (12 active studies)
- PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis · Phase 3 · Duke University
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Neurology & pain (7 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Diabetes & metabolic (5 active studies)
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Vaccines (2 active studies)
HIV / STI (1 active study)
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) · Phase 3 · Merck Sharp & Dohme LLC
Pediatric (1 active study)
- Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset · The University of Texas Health Science Center, Houston
Common conditions studied in Mobile
- Heart Failure (4 active studies)
- Breast Cancer (3 active studies)
- Cancer (3 active studies)
- Crohn's Disease (3 active studies)
- Malignant Solid Neoplasm (3 active studies)
- Multiple Myeloma (3 active studies)
Leading research sponsors in Mobile
- Children's Oncology Group
- AstraZeneca
- Merck Sharp & Dohme LLC
- Pfizer
- GlaxoSmithKline
Frequently asked questions
How many paid clinical trials are currently recruiting in Mobile?
There are approximately 121 recruiting clinical trials in Mobile, Alabama listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Mobile pay participants?
Most recruiting trials in Mobile compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Mobile?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Mobile?
The most common conditions under active study in Mobile include Heart Failure (4), Breast Cancer (3), Cancer (3), Crohn's Disease (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Mobile?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Mobile on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Mobile?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Mobile?
Recruiting research sites in Mobile include USA Health Strada Patient Care Center, Mobile Infirmary Medical Center, University of South Alabama, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Mobile right now?
The largest active categories in Mobile are Cancer & tumors (49), Cardiovascular (12), Neurology & pain (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.